查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1561533

2024-2032 年按產品、應用、疾病類型和地區分類的人類微生物組市場報告

Human Microbiome Market Report by Product, Application, Disease Type, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

2023年，全球人類微生物組市場IMARC Group達到8.17億美元。

人類微生物組是指人類遺傳肖像或宏基因組中發現的各種微生物內存在的基因。它由各種微生物組成，如細菌、真菌、原生動物、非生命病毒和眾多單細胞生物。這些生物體會影響人類生理機能，並有助於增強或損害代謝和免疫功能。它們存在於人體組織中，並針對醫學進步和分析技術進行研究。微生物組可用於益生菌、益生元、藥物以及各種疾病的診斷和治療系統，例如糖尿病、肥胖、癌症和代謝、胃腸道、神經系統、中樞神經系統和自體免疫疾病。

人類微生物組市場趨勢：

全球微生物失調導致的慢性生活方式疾病和感染的盛行率不斷上升，是推動市場成長的關鍵因素之一。此外，老年人口的增加更容易患此類疾病，這也推動了市場的成長。市場的成長也可歸因於人們越來越重視開發具有增強功效的人類微生物組療法。例如，人類腸道微生物組正在以特定的組合進行開發，以有效治療各種胃腸道疾病。與此一致的是，冠狀病毒（COVID-19）大流行的爆發也為市場成長提供了推動力。研究人員正在廣泛研究肺部微生物組，以分析感染的嚴重程度並開發適當的治療方法和疫苗。此外，各種進步，例如基於目標特異性微生物組的療法的開發，也有利於市場的成長。其他因素，包括廣泛的研發（R&D）活動，以及製藥業（尤其是發展中經濟體）的顯著成長，預計將推動市場成長。

本報告回答的關鍵問題：

  • 迄今為止，全球人類微生物組市場表現如何，未來幾年將如何表現？
  • COVID-19 對全球人類微生物組市場有何影響？
  • 主要區域市場有哪些？
  • 基於產品的市場區隔是什麼？
  • 基於應用的市場區隔是什麼？
  • 根據疾病類型的市場分類是怎樣的？
  • 產業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球人類微生物組市場的結構如何？
  • 產業競爭程度如何？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球人類微生物組市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品

  • 益生菌
    • 市場趨勢
    • 市場預測
  • 益生元
    • 市場趨勢
    • 市場預測
  • 診斷測試
    • 市場趨勢
    • 市場預測
  • 藥品
    • 市場趨勢
    • 市場預測
  • 醫療食品
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：按應用

  • 療法
    • 市場趨勢
    • 市場預測
  • 診斷
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：依疾病類型

  • 肥胖
    • 市場趨勢
    • 市場預測
  • 糖尿病
    • 市場趨勢
    • 市場預測
  • 自體免疫疾病
    • 市場趨勢
    • 市場預測
  • 癌症
    • 市場趨勢
    • 市場預測
  • 胃腸道疾病
    • 市場趨勢
    • 市場預測
  • 中樞神經系統疾病
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • 4D pharma plc
    • Atlas Biomed Group Limited
    • BIOHM
    • BiomX
    • Bione
    • DayTwo Inc.
    • ENTEROME
    • Ferring BV
    • Finch Therapeutics
    • Second Genome Inc.
    • SynBioBeta LLC
    • Synthetic Biologics Inc.
    • Vedanta Biosciences Inc.
    • Viome Inc.
Product Code: SR112024A4420

The global human microbiome market size reached US$ 817.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 3,586.3 Million by 2032, exhibiting a growth rate (CAGR) of 17.3% during 2024-2032.

The human microbiome refers to the genes present inside various microorganisms found in the genetic portrait, or metagenome, of humans. It consists of various microorganisms, such as bacteria, fungi, protozoans, non-living viruses and numerous single-celled organisms. These organisms impact human physiology and contribute to the enhancement or impairment of metabolic and immune functions. They are found in the human tissues and are studied for medical advancements and analytical techniques. Microbiomes are utilized in probiotics, prebiotics, pharmaceutical drugs and diagnostic and therapeutic systems for various ailments, such as diabetes, obesity, cancer and metabolic, gastrointestinal, neurological, central nervous system and autoimmune disorders.

Human Microbiome Market Trends:

The increasing prevalence of chronic lifestyle diseases and infections due to microbial dysbiosis across the globe is one of the key factors driving the market growth. Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the market growth. The growth of the market can also be attributed to the increasing emphasis on the development of human microbiome therapeutics with enhanced efficacy. For instance, human gut microbiomes are being developed in specific combinations for the effective treatment of various gastrointestinal ailments. In line with this, the onset of the coronavirus (COVID-19) pandemic is also providing a thrust to the market growth. Researchers are extensively studying the lung microbiomes to analyze the severity of the infections and develop appropriate therapeutics and vaccines. Additionally, various advancements, such as the development of target-specific microbiome-based therapies, are also favoring the growth of the market. Other factors, including extensive research and development (R&D) activities, along with significant growth in the pharmaceutical industry, especially in the developing economies, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global human microbiome market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and disease type.

Breakup by Product:

  • Probiotics
  • Prebiotics
  • Diagnostic Tests
  • Drugs
  • Medical Food
  • Others

Breakup by Application:

  • Therapeutics
  • Diagnostics

Breakup by Disease Type:

  • Obesity
  • Diabetes
  • Autoimmune Disorders
  • Cancer
  • Gastrointestinal Disorders
  • Central Nervous System Disorders
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 4D pharma plc, Atlas Biomed Group Limited, BIOHM, BiomX, Bione, DayTwo Inc., ENTEROME, Ferring B.V., Finch Therapeutics, Second Genome Inc., SynBioBeta LLC, Synthetic Biologics Inc., Vedanta Biosciences Inc. and Viome Inc.

Key Questions Answered in This Report:

  • How has the global human microbiome market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global human microbiome market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the disease type?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global human microbiome market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Human Microbiome Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Probiotics
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Prebiotics
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Diagnostic Tests
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Drugs
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Medical Food
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Therapeutics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Disease Type

  • 8.1 Obesity
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diabetes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Autoimmune Disorders
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cancer
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Gastrointestinal Disorders
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Central Nervous System Disorders
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 4D pharma plc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Atlas Biomed Group Limited
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 BIOHM
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 BiomX
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Bione
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 DayTwo Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 ENTEROME
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Ferring B.V.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Finch Therapeutics
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Second Genome Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 SynBioBeta LLC
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Synthetic Biologics Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Vedanta Biosciences Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
    • 14.3.14 Viome Inc.
      • 14.3.14.1 Company Overview
      • 14.3.14.2 Product Portfolio

List of Figures

  • Figure 1: Global: Human Microbiome Market: Major Drivers and Challenges
  • Figure 2: Global: Human Microbiome Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Human Microbiome Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Human Microbiome Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Human Microbiome Market: Breakup by Disease Type (in %), 2023
  • Figure 7: Global: Human Microbiome Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Human Microbiome (Probiotics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Human Microbiome (Probiotics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Human Microbiome (Prebiotics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Human Microbiome (Prebiotics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Human Microbiome (Diagnostic Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Human Microbiome (Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Human Microbiome (Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Human Microbiome (Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Human Microbiome (Medical Food) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Human Microbiome (Medical Food) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Human Microbiome (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Human Microbiome (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Human Microbiome (Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Human Microbiome (Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Human Microbiome (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Human Microbiome (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Human Microbiome (Obesity) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Human Microbiome (Obesity) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Human Microbiome (Diabetes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Human Microbiome (Diabetes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Human Microbiome (Autoimmune Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Human Microbiome (Autoimmune Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Human Microbiome (Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Human Microbiome (Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Human Microbiome (Gastrointestinal Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Human Microbiome (Gastrointestinal Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Human Microbiome (Central Nervous System Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Human Microbiome (Central Nervous System Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Human Microbiome (Other Disease Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Human Microbiome (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: North America: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: North America: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: United States: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: United States: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Canada: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Canada: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Asia-Pacific: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Asia-Pacific: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: China: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: China: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Japan: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Japan: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: India: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: India: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: South Korea: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: South Korea: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Australia: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Australia: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Indonesia: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Indonesia: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Others: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Others: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Europe: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Europe: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Germany: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Germany: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: France: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: France: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: United Kingdom: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: United Kingdom: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Italy: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Italy: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Spain: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Spain: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Russia: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Russia: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Latin America: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Latin America: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Brazil: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Brazil: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Mexico: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Mexico: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Others: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Others: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Middle East and Africa: Human Microbiome Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Middle East and Africa: Human Microbiome Market: Breakup by Country (in %), 2023
  • Figure 86: Middle East and Africa: Human Microbiome Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Global: Human Microbiome Industry: SWOT Analysis
  • Figure 88: Global: Human Microbiome Industry: Value Chain Analysis
  • Figure 89: Global: Human Microbiome Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Human Microbiome Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Human Microbiome Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Human Microbiome Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Human Microbiome Market Forecast: Breakup by Disease Type (in Million US$), 2024-2032
  • Table 5: Global: Human Microbiome Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Human Microbiome Market: Competitive Structure
  • Table 7: Global: Human Microbiome Market: Key Players